Otto C. Burghuber

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography.

H. Schurawitzki, R. Stiglbauer, W. Graninger et al. · Radiology · 1990 · 292 citations

Progressive Systemic Sclerosis, Medical Imaging, Advanced Lung Disease +15

Incidence and outcome of weaning from mechanical ventilation according to new categories

G-C. Funk, Shilo Anders, M.-K. Breyer et al. · European Respiratory Journal · 2009 · 270 citations · Full text

Asthma, Pulmonary Care, Critical Care Medicine +17

Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease

Philipp Eickhoff, Arschang Valipour, Dóra Kiss et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 247 citations